Phase 4 HIV and AIDS Trial, Recruiting (NCT07160075)

Phase 4 HIV and AIDS Trial, Recruiting NCT07160075 Sponsor: Cara Spence Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT07160075 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have tested negative for HIV
People whose doctor has assessed that their recent behaviours could put them at risk of HIV exposure
People who have been regularly attending an opioid replacement therapy (a program that helps manage dependence on opioids) program at least 3 days a week for the past 2 weeks
People who are willing to come back for follow-up visits during the trial

Who may not be able to join:

People who have reduced kidney function below a certain level, or who have a health condition or take a medication that is known to be unsafe when combined with either of the study medications (confirm with trial site)
People who have taken HIV prevention medication (PrEP) within the 24 hours before their screening or enrolment appointment
People whose doctor considers them to need HIV post-exposure medication (a short course of medication taken after a possible HIV exposure) at the time of their screening or enrolment appointment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07160075

Sponsor: Cara Spence

Phase: Phase 4

Status: Recruiting

Condition: HIV and AIDS

More information: https://clinicaltrials.gov/study/NCT07160075

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have tested negative for HIV
People whose doctor has assessed that their recent behaviours could put them at risk of HIV exposure
People who have been regularly attending an opioid replacement therapy (a program that helps manage dependence on opioids) program at least 3 days a week for the past 2 weeks
People who are willing to come back for follow-up visits during the trial

Who may not be able to join:

People who have reduced kidney function below a certain level, or who have a health condition or take a medication that is known to be unsafe when combined with either of the study medications (confirm with trial site)
People who have taken HIV prevention medication (PrEP) within the 24 hours before their screening or enrolment appointment
People whose doctor considers them to need HIV post-exposure medication (a short course of medication taken after a possible HIV exposure) at the time of their screening or enrolment appointment

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Cara Spence

Registry

ClinicalTrials.gov

Start date

28 August 2025

Est. completion

1 September 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Oral PrEP use in an OAT setting at 6 months follow-up: Review data from participant screening and clinical follow-up, and compare it to baseline PrEP use to assess uptake; Oral PrEP use in an OAT setting at 6 months follow-up: Record the time from offer to acceptance of PrEP

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov